(Q46506345)

22 December 2017

title

Improving local control with breast-conserving therapy: a 27-year single-institution experience (English)

1 reference

22 December 2017

10

Funda Meric-Bernstam

1 reference

22 December 2017

2

Kelly K Hunt

1 reference

22 December 2017

S. Eva Singletary

5

object named as

S Eva Singletary

1 reference

22 December 2017

Gildy V Babiera

7

object named as

Gildy V Babiera

1 reference

22 December 2017

author name string

Neslihan Cabioglu

1

1 reference

22 December 2017

Thomas A Buchholz

3

1 reference

22 December 2017

Nadeem Mirza

4

1 reference

22 December 2017

Henry M Kuerer

6

1 reference

22 December 2017

Frederick C Ames

8

1 reference

22 December 2017

Aysegul A Sahin

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Cancer

1 reference

22 December 2017

volume

104

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

20-29

1 reference

22 December 2017

Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

To boost or not to boost: decreasing radiation therapy in conservative breast cancer treatment when "inked" tumor resection margins are pathologically free of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Locally advanced noninflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Breast conservation in breast cancer: surgical and adjuvant considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

The influence of young age on outcome in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Canc

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Prognostic factors in patients undergoing curative irradiation for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Factors influencing the effect of age on prognosis in breast cancer: population based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

The importance of the lumpectomy surgical margin status in long-term results of breast conservation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Breast cancer. Experiences with conservation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21121

7 January 2021

Identifiers

DOI

10.1002/CNCR.21121

1 reference

22 December 2017

release_d7p22ugdzved7l6o5pvtqpi5vu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d7p22ugdzved7l6o5pvtqpi5vu

24 November 2022

mapped directly with Wikidata item

PubMed ID

15912514

1 reference

22 December 2017